TILLOTTS

Serial Number 98310161
Registration 7773606
700

Registration Progress

Application Filed
Dec 12, 2023
Under Examination
Approved for Publication
Mar 11, 2025
Published for Opposition
Mar 11, 2025
Registered
Apr 29, 2025

Trademark Image

TILLOTTS

Basic Information

Serial Number
98310161
Registration Number
7773606
Filing Date
December 12, 2023
Registration Date
April 29, 2025
Published for Opposition
March 11, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Apr 29, 2025
Registration
Registered
Classes
005 040 042 045

Rights Holder

Tillotts Pharma AG

03
Address
Baslerstrasse 15
Rheinfelden 4310
CH

Ownership History

Tillotts Pharma AG

Original Applicant
03
Rheinfelden CH

Tillotts Pharma AG

Owner at Publication
03
Rheinfelden CH

Tillotts Pharma AG

Original Registrant
03
Rheinfelden CH

Legal Representation

Attorney
Patrick J. Jennings

USPTO Deadlines

Next Deadline
2101 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2025-04-29)
Due Date
April 29, 2031
Grace Period Ends
October 29, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

23 events
Date Code Type Description Documents
Apr 29, 2025 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Apr 29, 2025 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Mar 11, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Mar 11, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
Mar 5, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Feb 15, 2025 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Feb 15, 2025 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Feb 15, 2025 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Feb 15, 2025 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Feb 15, 2025 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Feb 10, 2025 RCCK S SUSPENSION CHECKED - TO ATTORNEY FOR ACTION Loading...
Jul 27, 2024 GNSL F LETTER OF SUSPENSION E-MAILED Loading...
Jul 27, 2024 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Loading...
Jul 27, 2024 CNSL R SUSPENSION LETTER WRITTEN Loading...
Jul 11, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jul 11, 2024 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jul 11, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jul 11, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jul 11, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jul 11, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jul 11, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 14, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Dec 12, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations and substances, namely, preparations and substances for treating diseases and disorders of the gastro-intestinal tract
Class 040
Consulting services, namely, providing manufacturing assistance and advice in the field of drug manufacturing
Class 042
Pharmaceutical drug development services
Class 045
Consulting services, namely, providing regulatory compliance assistance with respect to the regulatory approval process for drugs

Classification

International Classes
005 040 042 045